Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins

Mouse peritoneal macrophages accumulate large amounts of cholesteryl ester when incubated with human low-density lipoprotein that has been modified by chemical acetylation (acetyl-LDL). This accumulation is related to a high-affinity cell surface binding site that mediates the uptake of acetyl-LDL by adsorptive endocytosis and its delivery to lysosomes. The current studies demonstrate that the cholesteryl ester accumulation can be considered in terms of a two-compartment model: (a) the incoming cholesteryl esters of acetyl-LDL are hydrolyzed in lysosomes, and (b) the resultant free cholesterol is re-esterified in the cytosol where the newly formed esters are stored as lipid droplets. The following biochemical and morphologic evidence supports the hydrolysis-re-esterification mechanism: (a) Incubation of macrophages with acetyl-LDL markedly increased the rate of cholesteryl ester synthesis from [14C]oleate, and this was accompanied by an increase in the acyl-CoA:cholesteryl acyltransferase activity of cell-free extracts. (b) When macrophages were incubated with reconstituted acetyl- LDL in which the endogenous cholesterol was replaced with [3H]- cholesteryl linoleate, the [3H]cholesteryl linoleate was hydrolyzed, and at least one-half of the resultant [3H]cholesterol was re- esterified to form [3H]cholesteryl oleate, which accumulated within the cell. The lysosomal enzyme inhibitor chloroquine inhibited the hydrolysis of the [3H]cholesteryl linoleate, thus preventing the formation of [3H]cholesteryl oleate and leading to the accumulation of unhydrolyzed [3H]cholesteryl linoleate within the cells. (c) In the electron microscope, macrophages incubated with acetyl-LDL had numerous cytoplasmic lipid droplets that were not surrounded by a limiting membrane. The time course of droplet accumulation was similar to the time course of cholesteryl ester accumulation as measured biochemically. (d) When acetyl-LDL was removed from the incubation medium, biochemical and morphological studies showed that cytoplasmic cholesteryl esters were rapidly hydrolyzed and that the resultant free cholesterol was excreted from the cell.

[1]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Fowler,et al.  Participation of lysosomes in atherosclerosis. , 1978, The New England journal of medicine.

[3]  T. Peters,et al.  The submicrosomal localization of acyl-coenzyme A-cholesterol acyltransferase and its substrate, and of cholesteryl esters in rat liver. , 1978, The Biochemical journal.

[4]  M. Brown,et al.  Familial hypercholesterolemia: pathogenesis of a receptor disease. , 1978, The Johns Hopkins medical journal.

[5]  M. Krieger,et al.  Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle. , 1978, The Journal of biological chemistry.

[6]  A. J. Day,et al.  Composition and metabolism of lipid in macrophages from normally fed and cholesterol-fed rabbits. , 1978, Experimental and molecular pathology.

[7]  Richard G. W. Anderson,et al.  RECEPTOR-MEDIATED UPTAKE OF MACROMOLECULES AND THEIR DELIVERY TO LYSOSOMES IN HUMAN FIBROBLASTS , 1978 .

[8]  S. Basu,et al.  Metabolism of cationized lipoproteins by human fibroblasts: biochemical and morphologic correlations , 1977, The Journal of cell biology.

[9]  M. Brown,et al.  Overloading human aortic smooth muscle cells with low density lipoprotein-cholesteryl esters reproduces features of atherosclerosis in vitro. , 1977, The Journal of clinical investigation.

[10]  D. Small.  Liquid crystals in living and dying systems , 1977 .

[11]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[12]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Brown,et al.  Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. , 1976, The Journal of biological chemistry.

[14]  M. Brown,et al.  The LDL pathway in human fibroblasts: a receptor-mediated mechanism for the regulation of cholesterol metabolism. , 1976, Current topics in cellular regulation.

[15]  A. Beaudet,et al.  Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. , 1975, The Journal of biological chemistry.

[16]  M. Brown,et al.  Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. , 1975, The Journal of biological chemistry.

[17]  W. Roberts,et al.  Tuberous xanthoma in homozygous type II hyperlipoproteinemia. A histologic, histochemical, and electron microscopical study. , 1975, Archives of pathology.

[18]  M. Brown,et al.  Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols. , 1975, The Journal of biological chemistry.

[19]  M. Brown,et al.  Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts. , 1975, The Journal of clinical investigation.

[20]  M. Brown,et al.  Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[22]  H. Shio,et al.  Lysosomes of the arterial wall. IV. Cytochemical localization of acid phosphatase and catalase in smooth muscle cells and foam cells from rabbit atheromatous aorta. , 1974, The American journal of pathology.

[23]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[24]  N. Baker,et al.  Characteristics of the Cholesterol‐Esterifying Activity in Normal and Atherosclerotic Rabbit Aortas , 1974, Circulation research.

[25]  E. B. Smith,et al.  The relationship between plasma and tissue lipids in human atherosclerosis. , 1974, Advances in lipid research.

[26]  Z. Werb,et al.  CHOLESTEROL METABOLISM IN THE MACROPHAGE III. INGESTION AND INTRACELLULAR FATE OF CHOLESTEROL AND CHOLESTEROL ESTERS , 1972 .

[27]  D. B. Zilversmit,et al.  The role of phagocytosis in the development of atherosclerotic lesions in the rabbit. , 1971, Atherosclerosis.

[28]  M. Wahlqvist,et al.  Incorporation of Oleic Acid into Lipid by Foam Cells in Human Atherosclerotic Lesions , 1969, Circulation research.

[29]  D. Goodman.  Cholesterol ester metabolism. , 1965, Physiological reviews.

[30]  D. Goodman,et al.  THE FORMATION OF CHOLESTEROL ESTERS WITH RAT LIVER ENZYMES. , 1964, The Journal of biological chemistry.

[31]  A. George.  The metabolic basis of inherited disease , 1961 .

[32]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[33]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.